JPMorgan Chase & Co’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.94M | Buy |
195,189
+177,764
| +1,020% | +$1.77M | ﹤0.01% | 3365 |
|
|
2025
Q1 | $165K | Buy |
17,425
+745
| +4% | +$7.07K | ﹤0.01% | 4516 |
|
|
2024
Q4 | $230K | Sell |
16,680
-39,519
| -70% | -$545K | ﹤0.01% | 4483 |
|
|
2024
Q3 | $855K | Buy |
56,199
+45,381
| +419% | +$690K | ﹤0.01% | 3732 |
|
|
2024
Q2 | $51.6K | Sell |
10,818
-80,265
| -88% | -$383K | ﹤0.01% | 4892 |
|
|
2024
Q1 | $618K | Buy |
+91,083
| New | +$618K | ﹤0.01% | 3832 |
|
|
2021
Q3 | – | Sell |
-77
| Closed | – | – | 5529 |
|
|
2021
Q2 | $0 | Buy |
+77
| New | – | ﹤0.01% | 5489 |
|
|
2020
Q4 | – | Sell |
-5,607
| Closed | -$30K | – | 4898 |
|
|
2020
Q3 | $30K | Buy |
5,607
+5,600
| +80,000% | +$30K | ﹤0.01% | 4414 |
|
|
2020
Q2 | $0 | Buy |
+7
| New | – | ﹤0.01% | 4741 |
|
|
2017
Q4 | – | Sell |
-200
| Closed | -$4K | – | 4653 |
|
|
2017
Q3 | $4K | Hold |
200
| – | – | ﹤0.01% | 4138 |
|
|
2017
Q2 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 4224 |
|